Abstract:Post-transcriptional RNA modification is an emerging epigenetic control mechanism in cells that is important in many different cellular and organismal processes. N6-methyladenosine (m 6 A) is one of the most prevalent, prolific, and ubiquitous internal transcriptional alterations in eukaryotic mRNAs, making it an important topic in the field of Epigenetics. m 6 A methylation acts as a dynamical regulatory process that regulates the activity of genes and participates in multiple physiological processes, by supporting multiple aspects of essential mRNA metabolic processes, including pre-mRNA splicing, nuclear export, translation, miRNA synthesis, and stability. Extensive research has linked aberrations in m 6 A modification and m 6 A-associated proteins to a wide range of human diseases. However, the impact of m 6 A on mRNA metabolism and its pathological connection between m 6 A and other non-communicable diseases, including cardiovascular disease, neurodegenerative disorders, liver diseases, and cancer remains in fragmentation. Here, we review the existing understanding of the overall role of mechanisms by which m 6 A exerts its activities and address new discoveries that highlight m 6 A's diverse involvement in gene expression regulation. We discuss m 6 A deposition on mRNA and its consequences on degradation, translation, and transcription, as well as m 6 A methylation of non-coding chromosomal-associated RNA species. This study could give new information about the molecular process, early detection, tailored treatment, and predictive evaluation of human non-communicable diseases like cancer. We also explore more about new data that suggests targeting m 6 A regulators in diseases may have therapeutic advantages.

RNA N6-methyladenosine modification in female reproductive biology and pathophysiology

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

N6-Methyladenosine Modifications in the Female Reproductive System: Roles in Gonad Development and Diseases

The emerging roles of N6-methyladenosine RNA methylation in human cancers

The Role of N 6-methyladenosine Modification in Gametogenesis and Embryogenesis: Impact on Fertility

The Role of N6-methyladenosine Modification in Gametogenesis and Embryogenesis: Impact on Fertility

The Roles of M6a RNA Modifiers in Human Cancer

m6A modification of RNA in cervical cancer: role and clinical perspectives

Genetic Regulation of N6-Methyladenosine-RNA in Mammalian Gametogenesis and Embryonic Development

Role of m6A modification in female infertility and reproductive system diseases

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

Exploring the Role of M6a Modification in the Great Obstetrical Syndromes

RNA M6a Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications.

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

Effects of N6-methyladenosine modification on the function of the female reproductive system

Epigenetic regulation of adipose tissue expansion and adipogenesis by<i>N</i><SUP>6</SUP>-methyladenosine

Regulation of m6Am RNA modification and its implications in human diseases

Role of RNA N6-Methyladenosine Modification in Male Infertility and Genital System Tumors

Regulatory roles of N6-methyladenosine (m 6 A) methylation in RNA processing and non-communicable diseases